Kazia Therapeutics Ltd. is a clinical stage oncology company, which engages in the pharmaceutical research and development business. The company was founded by Graham Edmund Kelly in March 1994 and is headquartered in Sydney, Australia.
Company Profile
SymbolKZIA
Company NameKazia Therapeutics
Listing DateJan 7, 1999
Founded1994
CEODr. John E. Friend, II,M.D.
MarketNASDAQ
Employees16
Securities TypeDR
ADS Ratio1.0 : 10.0
Fiscal Year Ends06-30
AddressThree International Towers,300 Barangaroo Avenue,Level 24